Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive interstitial lung disease with increasing incidence and poor prognosis, with a median survival of approximately 3 years. Although antifibrotic therapies such as nintedanib and pirfenidone offer mode... ...

请注册登录后继续浏览